Abstract
Our ability to study thousands of genes simultaneously over the last few years owing not only to the development of DNA microarray technology, but also to large-scale yeast two-hybrid and other methods, has brought about a paradigmatic shift in biology. Armed with the complete sequences of several genomes including humans, more and more biomedical investigators are now interested in understanding the functions of gene products, or proteins, on a global scale. In this article, the promises and pitfalls of two methods used for proteomics studies - protein microarrays and mass spectrometry - towards achieving this goal are discussed.
Keywords: paradigmatic, protein microarrays, spectrometry, genomes, Proteomics
Current Genomics
Title: Microarrays and Mass Spectrometry - The Future of Proteomics
Volume: 4 Issue: 7
Author(s): K. S. Deshpande, H. C. Harsha and A. Pandey
Affiliation:
Keywords: paradigmatic, protein microarrays, spectrometry, genomes, Proteomics
Abstract: Our ability to study thousands of genes simultaneously over the last few years owing not only to the development of DNA microarray technology, but also to large-scale yeast two-hybrid and other methods, has brought about a paradigmatic shift in biology. Armed with the complete sequences of several genomes including humans, more and more biomedical investigators are now interested in understanding the functions of gene products, or proteins, on a global scale. In this article, the promises and pitfalls of two methods used for proteomics studies - protein microarrays and mass spectrometry - towards achieving this goal are discussed.
Export Options
About this article
Cite this article as:
Deshpande S. K., Harsha C. H. and Pandey A., Microarrays and Mass Spectrometry - The Future of Proteomics, Current Genomics 2003; 4 (7) . https://dx.doi.org/10.2174/1389202033490213
DOI https://dx.doi.org/10.2174/1389202033490213 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways
Current Cancer Therapy Reviews Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition
Current Cancer Drug Targets Breast Cancer Chemoprevention: Current Perspectives
Current Enzyme Inhibition Meet Our Editorial Board Member
Current Organic Synthesis Estrogen Activates Classical and Alternative Mechanisms to Orchestrate Neuroprotection
Current Neurovascular Research D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections.
Current Cancer Drug Targets Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets
Current Pharmaceutical Design Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways
Anti-Cancer Agents in Medicinal Chemistry Substance P: Structure, Function, and Therapeutics
Current Topics in Medicinal Chemistry The Multiple Roles of Vitamin D in Human Health. A Mini-Review
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Synthesis of Oleanolic Acid Analogues and Their Cytotoxic Effects on 3T3 Cell Line
Medicinal Chemistry Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer
Current Drug Targets Molecular Docking Studies of the Antitumoral Activity and Characterization of New Chalcone
Current Topics in Medicinal Chemistry The Antiangiogenic and Antitumoral Activity of Titanocene Y* In Vivo
Letters in Drug Design & Discovery Gene Transfer with Sequence-Defined Oligo(ethanamino)amides Bioreducibly Attached to a Propylenimine Dendrimer Core
Pharmaceutical Nanotechnology Boronic Acid-based Enzyme Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry Enrichment of Up-regulated and Down-regulated Gene Clusters Using Gene Ontology, miRNAs and lncRNAs in Colorectal Cancer
Combinatorial Chemistry & High Throughput Screening Electric cable: cytoskeleton as an electric transmitter for cancer therapy
Current Signal Transduction Therapy Up-Regulation of MBD1 Promotes Pancreatic Cancer Cell Epithelial-Mesenchymal Transition and Invasion by Epigenetic Down-Regulation of E-Cadherin
Current Molecular Medicine The Pros and Cons of Targeting Protein Kinase c (PKC) in the Management of Cancer Patients
Current Pharmaceutical Biotechnology